ArticleHematology, transfusion and cell therapy2026
Reference intervals for indices derived from the complete blood count in the Longitudinal Study of Adult Health (ELSA-Brasil).
Article in Hematology, transfusion and cell therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHematological biomarkers from routine tests are attractive for their accessibility and clinical applicability, particularly indices derived from the complete blood count. Establishing reference intervals is essential for accurate interpretation, requiring healthy populations and standardized methods following Clinical and Laboratory Standards Institute guidelines.
objectiveTo establish reference intervals for complete blood count-derived indices in healthy adults.
methodsThis cross-sectional study analyzed baseline data from 2230 participants aged 35-74 years in the Brazilian Longitudinal Study of Adult Health. Individuals with inflammatory conditions or hematological extremes (<1st and >99th percentiles) were excluded. Evaluated cellular parameters comprised five inflammatory ratios (neutrophil-to-lymphocyte, platelet-to-lymphocyte, lymphocyte-to-monocyte, monocyte-to-lymphocyte, and derived neutrophil-to-lymphocyte) and three composite indices (systemic inflammatory response, aggregate index of systemic inflammation, and systemic immune-inflammation). Reference intervals corresponded to the 2.5th-97.5th percentiles. Group differences by sex and age were evaluated using Mann-Whitney and Harris-Boyd tests.
resultsMales constituted 54.3% of the sample, and 92.0% of the participants were aged 35-59 years. Neither sex nor age required data stratification. The established reference intervals were: neutrophil-to-lymphocyte ratio (0.95-3.28), platelet-to-lymphocyte ratio (77.25-213.27), lymphocyte-to-monocyte ratio (2.27-7.17), monocyte-to-lymphocyte ratio (0.14-0.44), derived neutrophil-to-lymphocyte ratio (0.72-2.33), systemic inflammatory response index (0.33-1.89), aggregate index of systemic inflammation (69.85-460.01), and systemic immune-inflammation index (201.64-830.02).
conclusionThese reference intervals provide a basis for clinical and epidemiological studies on subclinical inflammation and chronic disease risk.
Indexed as
Identifiers
42880187What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.